Clinical Trial Update: Central Effects of Botulinum Toxin: Neurophysiological Study in Stroke Patients With Spastic Lower Limb [Phase 3]

View source ↗

Summary

Phase 3 clinical trial assessing central effects of botulinum toxin in stroke patients with spastic lower limbs.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Botulinum toxin (botulinum toxin)

Snippet

Sponsor: Assistance Publique Hopitaux De Marseille | Conditions: Hemiplegic Patients Post-AVC | Phase 3 | Status: UNKNOWN